DSM-5 anxiety refers to the classification and diagnostic criteria for anxiety disorders as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), published by the American Psychiatric Association (APA) in 2013. The current version, DSM-5-TR (Text Revision), continues to provide the standardised framework that mental health professionals use to diagnose these conditions consistently across different healthcare settings. A fundamental change in DSM-5 was the removal of obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD) from the anxiety disorders chapter, placing them in new separate categories based on research showing they have distinct underlying mechanisms.
Fear is an emotional response to an immediate threat, while anxiety is anticipation of a future threat.
The DSM-5 anxiety disorders chapter now comprises eleven distinct conditions, including separation anxiety disorder, selective mutism, specific phobia, social anxiety disorder (social phobia), panic disorder, agoraphobia, and generalised anxiety disorder (GAD) . Each disorder shares core features of excessive fear and anxiety as well as related behavioural disturbances, but they differ in the types of situations that trigger symptoms and associated cognitive ideation. For GAD specifically, diagnosis requires excessive anxiety and worry occurring more days than not for at least 6 months, accompanied by three or more of six key symptoms: restlessness, fatigue, difficulty concentrating, irritability, muscle tension, or sleep disturbance.
What makes DSM-5 anxiety classification particularly compelling is the emphasis on differential diagnosis and ruling out other causes. Clinicians must ensure symptoms are not attributable to substance use, medication effects, or another medical condition, such as hyperthyroidism or heart disease, which can mimic anxiety. The manual provides structured clinical interviews and standardised assessment tools like the GAD-7 questionnaire and Panic Disorder Severity Scale (PDSS) to measure symptom severity. Additionally, the DSM-5 includes cultural formulation guidelines, recognising that anxiety expression varies across cultures—for example, in Japan and Korea, social anxiety may manifest as taijin kyofusho, involving fears of offending others rather than being embarrassed.
DSM-5 anxiety represents a rigorously defined diagnostic framework that transforms the complex experience of persistent fear into standardised, measurable criteria—requiring specific symptom counts, duration thresholds (typically 6 months), and clinically significant impairment—while acknowledging cultural variations and ensuring that the 28.8% lifetime prevalence of anxiety disorders among American adults receives consistent, accurate diagnosis and appropriate treatment .
